国产中文无码av每日更新在线观看, 亚洲天堂中文字幕一区二区三区免费, 国产口爆吞精在线观视频-黄色国产, 92福利-国内精品久久久久久99,亚洲成AV人A片不卡无码,浪潮AV无码专区,老熟女败火白浆,中文字幕日产av,色情日本免费看大片

更新于 7月23日

Research Scientist

1.5-3萬(wàn)
  • 上海浦東新區(qū)
  • 1-3年
  • 博士
  • 全職
  • 招1人

職位描述

生物
POSITION DESCRIPTION:
Iasobio-shanghai innovation center is seeking a Research Investigator with the following duties:
?Develop new assay to address analytical characterization need for various cell therapy programs
?independently go through published literatures and design innovative experiments to find technical solutions for complex biological questions
?perform routine testing and characterization of cell therapy products using existing and developed analytical assays and immunological methods
?manage and maintain critical material inventory for different programs; document personal experimental results accurately and completely in laboratory notebook; contribute to technical documents such as test methods, reports, protocols, and internal presentations
?present study results at team or department meetings to external partners or at conferences
?contribute to technical transfer of experimental data/procedures internally and external stakeholders as appropriate; and collaborate departmentally as well as cross functionally with peers on project work as appropriate.
REQUIREMENTS:
PhD’s degree in biotechnology, immunology, cell biology or related field, plus 2 years of related experience. Prior experience must include:
?Develop and validate CAR-T generation method using viral vector or non-viral vector delivery system in support of ex vivo and in vivo delivery.
?maintain immune and tumor cell lines to develop tumor models
?Conduct ex-vivo experiments to test the efficacy of experimental CAR-T cells on tumor cells in vitro as well as in vivo
?Perform immunophenotyping using flow cytometry to assess different immune cell populations
?Characterize CAR-T function and persistence using T cell activation, cell killing (single and repeated cycle) as well as safety control by logic gating.
?Execute cytokine analysis from supernatant of CAR-T-treated tumor samples using ELISA or Luminex

工作地點(diǎn)

浦東新區(qū)上海馴鹿生物技術(shù)有限公司

職位發(fā)布者

張欣/人事經(jīng)理

昨日活躍
立即溝通
公司Logo南京馴鹿生物技術(shù)股份有限公司
南京馴鹿醫(yī)療技術(shù)有限公司由臨床團(tuán)隊(duì)、生物制藥科學(xué)家和投資人團(tuán)隊(duì)聯(lián)合創(chuàng)立,致力于腫瘤細(xì)胞免疫治療的藥物開發(fā)及技術(shù)服務(wù)。馴鹿醫(yī)療管理團(tuán)隊(duì)多數(shù)來源于生物制藥上市公司,具有生物制藥產(chǎn)業(yè)化背景和熟練的前端研發(fā)向臨床轉(zhuǎn)化能力。公司的國(guó)際化臨床專家團(tuán)隊(duì)擁有豐富的細(xì)胞治療產(chǎn)品研發(fā)和臨床應(yīng)用經(jīng)驗(yàn),為研發(fā)產(chǎn)品精準(zhǔn)定位及開發(fā)成功率提供有力的保障。公司位于南京生物醫(yī)藥谷,現(xiàn)有近5000平的科研及產(chǎn)業(yè)化基地。2017年11月,按照歐盟標(biāo)準(zhǔn)設(shè)計(jì)的質(zhì)粒、病毒及細(xì)胞制備GMP車間正式落成。馴鹿醫(yī)療以抗腫瘤新藥創(chuàng)新及創(chuàng)造生命的奇跡為己任,產(chǎn)品研發(fā)定位于擁有全球自有知識(shí)產(chǎn)權(quán)與具備國(guó)際化創(chuàng)新能力。公司的產(chǎn)品涵蓋抗體;CAR-T細(xì)胞治療血液腫瘤、部分實(shí)體瘤、病毒感染類腫瘤及通用型CAR-T;系列的細(xì)胞治療預(yù)前及預(yù)后檢測(cè)產(chǎn)品;細(xì)胞因子風(fēng)暴控制等。針對(duì)血液腫瘤的CAR-T產(chǎn)品通過在合作臨床機(jī)構(gòu)的臨床試驗(yàn)驗(yàn)證,治療效果與國(guó)際同步,并在細(xì)胞治療副作用控制及延緩復(fù)發(fā)上具有明顯優(yōu)勢(shì)。公司已完成由國(guó)內(nèi)生物制藥上市公司領(lǐng)投的c輪融資。公司管理團(tuán)隊(duì)有著豐富的規(guī)范管理及資本運(yùn)營(yíng)經(jīng)驗(yàn),公司計(jì)劃3年內(nèi)實(shí)現(xiàn)上市。公司獨(dú)特的合伙人制度及全員持股計(jì)劃呼喚有夢(mèng)想的你加盟。馴鹿,擁有獨(dú)具一格的辦公環(huán)境、國(guó)際化的研發(fā)及生產(chǎn)平臺(tái)、有競(jìng)爭(zhēng)力的薪酬制度,更是創(chuàng)造生命奇跡、具有夢(mèng)想的舞臺(tái)。馴鹿尋你,一“鹿”同行。
公司主頁(yè)